The influence of fluid physicochemical properties on vibrating-mesh nebulization.

In this study, the effect of fluid physicochemical properties and the vibrating-mesh mechanism on the aerosols generated from vibrating-mesh nebulizers have been evaluated using fluids having a range of viscosity, surface tension and ion concentration. Two nebulizers were investigated: the Omron MicroAir NE-U22 (passively vibrating) and the Aeroneb Pro (actively vibrating) mesh nebulizers. For both devices, the total aerosol output was generally unaffected by fluid properties. Increased viscosity or ion concentration resulted in a decrease in droplet volume median diameter (VMD) and an increase in fine particle fraction (FPF). Moreover, increased viscosity resulted in prolonged nebulization and reduced output rate, particularly for the Omron nebulizer. Both nebulizers were unsuitable for delivery of viscous fluids since nebulization was intermittent or completely ceased at >1.92cP. The presence of ions reduced variability particularly for the Aeroneb Pro nebulizer. No clear effect of surface tension was observed on the performance of nebulizers employing a vibrating-mesh technology. However, when viscosity was low, reduced surface tension seemed advantageous in shortening the nebulization time and increasing the output rate, but for the Omron nebulizer this also increased the droplet VMD and decreased the FPF. This study has shown that vibrating-mesh nebulization was highly dependent on fluid characteristics and nebulizer mechanism of operation.

[1]  H. Kristensen,et al.  Factors influencing the in vitro deposition of tobramycin aerosol: a comparison of an ultrasonic nebulizer and a high-frequency vibrating mesh nebulizer. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[2]  T. Arakawa,et al.  Some Factors Associated with the Ultrasonic Nebulization of Proteins , 2004, Pharmaceutical Research.

[3]  B. C. Garrett,et al.  Ions at the Air/Water Interface , 2004, Science.

[4]  S. Clarke,et al.  Choice of nebulisers and compressors for delivery of carbenicillin aerosol. , 1986, European journal of respiratory diseases.

[5]  M. King,et al.  Lung delivery of aerosolized dextran. , 2000, American journal of respiratory and critical care medicine.

[6]  K. Taylor,et al.  Nebulization of Fluids of Different Physicochemical Properties with Air-Jet and Ultrasonic Nebulizers , 1995, Pharmaceutical Research.

[7]  T. Anchordoquy,et al.  Rationale for the selection of an aerosol delivery system for gene delivery. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[8]  Abdelbary Elhissi,et al.  Delivery of liposomes generated from proliposomes using air-jet, ultrasonic and vibrating mesh nebulisers , 2004 .

[9]  D. Hendrick,et al.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. , 1990, Thorax.

[10]  R. Dhand Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. , 2002, Respiratory care.

[11]  O.N.M. Mc Callion,et al.  Viscosity effects on nebulisation of aqueous solutions , 1996 .

[12]  H. Katinger,et al.  Nebulization of Liposomal rh-Cu/Zn–SOD with a Novel Vibrating Membrane Nebulizer , 2006, Journal of liposome research.

[13]  H. Steckel,et al.  Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  W. Sadee Pharmacogenomics: The implementation phase , 2002, AAPS PharmSci.

[15]  K. Taylor,et al.  Formulations generated from ethanol‐based proliposomes for delivery via medical nebulizers , 2006, The Journal of pharmacy and pharmacology.

[16]  Hans Schreier,et al.  Aerosolization of lipoplexes using AERx® pulmonary delivery system , 2008, AAPS PharmSci.

[17]  S. Smye,et al.  Measurement and prediction of drug solvent losses by evaporation from a jet nebuliser. , 1992, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[18]  C O'Callaghan,et al.  The science of nebulised drug delivery , 1997, Thorax.

[19]  O.N.M. Mc Callion,et al.  The influence of surface tension on aerosols produced by medical nebulisers , 1996 .

[20]  A. Clark The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .

[21]  D. Cockcroft,et al.  Importance of evaporative water losses during standardized nebulized inhalation provocation tests. , 1989, Chest.

[22]  S. S. Davis,et al.  Physico-chemical studies on aerosol solutions for drug delivery I. Water-propylene glycol systems , 1978 .

[23]  J. Fink,et al.  Nebulization of Steroid Suspension: An In Vitro Evaluation of the Aeroneb® Go and the Pari LC Plus™ Nebulizers , 2004 .

[24]  J. Weber,et al.  Properties of aerosols produced with three nebulizers. , 2015, The American review of respiratory disease.

[25]  H. Steckel,et al.  Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  A. Coates,et al.  The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. , 1997, Chest.

[27]  S. Clarke,et al.  Evaluation of jet nebulisers for use with gentamicin solution. , 1985, Thorax.